News|Articles|May 7, 2025
Advances and Insights in Atopic Dermatitis Management
This comprehensive publication explores the current landscape and emerging therapies in the treatment of atopic dermatitis, with a particular focus on the use of topical phosphodiesterase-4 (PDE4) inhibitors. It includes insights into immune dysregulation in AD, limitations of conventional therapies, and evolving treatment options aimed at improving patient outcomes and adherence.
Advertisement
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss
2
This Year in Primary Care: 10 Critical Updates in 2025
3
FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management
4
FDA Approves Abbott Volt Pulsed Field Ablation System for Treatment of Atrial Fibrillation
5

























































































































































































































































































